文献速递神经MR

胶质瘤分级与IDH1突变状态:体素内不相干运动MRI评估

Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI.
PubMed 文献 · Clin Radiol · 2019-04-20

研究对42例胶质瘤患者术前行3T MRI体素内不相干运动成像(10个b值,0-1200 s/mm2),计算肿瘤内及对侧正常白质的灌注分数f、真实扩散系数D、伪扩散系数D*和ADC,比较高级别与低级别胶质瘤间及IDH1野生型与突变型间的差异,并分析ROC。结果显示IVIM可鉴别胶质瘤分级并预测IDH1突变状态。

要点

  • 高级别胶质瘤较低级别ADC和D更低、D*和f更高,ADC的AUC为0.937。
  • 低级别胶质瘤中IDH1突变型ADC高于野生型,AUC为0.936。
  • 高级别胶质瘤中IDH1突变型ADC更高、D*和f更低,f的AUC为0.992。

核心结论

  • IVIM可鉴别胶质瘤分级并预测IDH1突变状态。

研究设计与样本

  • 术前对42例胶质瘤患者行3T MRI IVIM成像,使用10个b值(0-1200 s/mm2),计算肿瘤内及对侧正常白质的f、D、D*和ADC。

诊断标准与关键数值

  • 高级别胶质瘤较低级别胶质瘤ADC更低(0.989×10-3 vs 1.243×10-3 mm2/s,p<0.001),AUC为0.937。
  • 高级别胶质瘤较低级别胶质瘤D更小(0.849×10-3 vs 1.062×10-3 mm2/s,p=0.001),AUC为0.898。
  • 高级别胶质瘤较低级别胶质瘤D*更大(9.731×10-3 vs 5.442×10-3 mm2/s,p=0.006),AUC为0.770。
  • 高级别胶质瘤较低级别胶质瘤f值更大(0.204 vs 0.130,p<0.001),AUC为0.838。
  • 低级别胶质瘤中IDH1突变型ADC高于野生型(1.286×10-3 vs 1.122×10-3 mm2/s,p=0.003),AUC为0.936。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess the diagnostic performance of intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) in differentiating high-grade gliomas (HGGs) from low-grade gliomas (LGGs), and predicting the isocitrate dehydrogenase 1 (IDH1) mutational status.

MATERIALS AND METHODS: IVIM imaging was performed preoperatively in 42 patients with gliomas using 10 b-values (0-1,200 s/mm2) in a 3 T MRI machine. The perfusion fraction (f), true diffusion coefficient (D), pseudo-diffusion coefficient (D*), and apparent diffusion coefficient (ADC) were calculated within the tumours and in the contralateral normal white matter, and the values were compared between the HGGs and LGGs, and between IDH1 wild-type and mutated-type gliomas. In addition, the receiver operating characteristic (ROC) was also analysed.

RESULTS: When compared to LGGs, HGGs had lower ADC (0.989×10-3 versus 1.243×10-3 mm2/s, p<0.001), smaller D (0.849×10-3 versus 1.062×10-3 mm2/s, p=0.001), larger D* (9.731×10-3 versus 5.442×10-3 mm2/s, p=0.006), and bigger f-values (0.204 versus 0.130, p<0.001) within the tumours. The area under the receiver operating characteristic (ROC) curve (AUC) was 0.937, 0.898, 0.770, and 0.838, respectively. Among the LGGs, tumours with the IDH1 mutation had a higher ADC (1.286×10-3 mm2/s), when compared to the wild-type IDH1 (1.122×10-3 mm2/s, p=0.003), with an AUC of 0.936. In HGGs, tumours with the IDH1 mutation had higher ADC (1.056×1010-3 versus 0.946×10-3 mm2/s, p=0.030), smaller D* (6.204×10-3 versus 11.999×10-3 mm2/s, p=0.023) and smaller f-values (0.143 versus 0.244, p<0.001), with an AUC of 0.766, 0.841 and 0.992, respectively.

CONCLUSION: Glioma grading can be differentiated and IDH1 mutational status can be predicted using IVIM.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Wang X, Chen XZ, Shi L, et al. Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI. Clin Radiol. 2019. PMID: 31014573. doi:10.1016/j.crad.2019.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。